These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11363839)

  • 21. Antiviral roundup.
    Smart T; Torres G
    GMHC Treat Issues; 1996 Aug; 10(8):6-7. PubMed ID: 11363720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rescue me.
    Simmons P
    Res Initiat Treat Action; 1998 Aug; 4(5):10. PubMed ID: 11365705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FDA Advisory Committee stalemates on delavirdine.
    AIDS Patient Care STDS; 1997 Apr; 11(2):96-7. PubMed ID: 11361773
    [No Abstract]   [Full Text] [Related]  

  • 24. HIV treatment options.
    Smith D
    AIDS Treat News; 1998 May; (No 294):4-5. PubMed ID: 11365404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding the reverse transcriptase inhibitors in HIV.
    Edmonds-Ogbuokiri J
    Fac Notes (New Orleans La); 1998; 10(6):13-5. PubMed ID: 11366142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antivirals update.
    Proj Inf Perspect; 1998 Dec; (26):8-10. PubMed ID: 11366501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection.
    Barry M; Mulcahy F; Merry C; Gibbons S; Back D
    Clin Pharmacokinet; 1999 Apr; 36(4):289-304. PubMed ID: 10320951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protease inhibitors at a glance...
    Notes Undergr; 1998-1999 Winter; (No 38):suppl 1-4. PubMed ID: 11366198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NNRTI plus PI combinations in the perspective of nucleoside-sparing or nucleoside-failing antiretroviral regimens.
    Joly V; Descamps D; Yeni P
    AIDS Rev; 2002; 4(3):128-39. PubMed ID: 12416447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disorders of lipid metabolism in patients with HIV disease treated with antiretroviral agents: frequency, relationship with administered drugs, and role of hypolipidaemic therapy with bezafibrate.
    Manfredi R; Chiodo F
    J Infect; 2001 Apr; 42(3):181-8. PubMed ID: 11545549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protease inhibitors and nucleoside combinations, or, Alice in Gaithersburg.
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):23-32, 37. PubMed ID: 11363515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can delavirdine substitute for ritonavir?
    TreatmentUpdate; 2001; 13(7):8. PubMed ID: 11794866
    [No Abstract]   [Full Text] [Related]  

  • 33. Antiviral therapy: how simple can you get?
    Gilden D
    GMHC Treat Issues; 1998 Nov; 12(11):3-7. PubMed ID: 11365906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study.
    Young J; Weber R; Rickenbach M; Furrer H; Bernasconi E; Hirschel B; Tarr PE; Vernazza P; Battegay M; Bucher HC
    Antivir Ther; 2005; 10(5):585-91. PubMed ID: 16152752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protease inhibitor new math.
    Gilden D
    GMHC Treat Issues; 1996 May; 10(5):3-6. PubMed ID: 11363583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-HIV drug update.
    Proj Inf Perspect; 2000 Aug; (30):5-6. PubMed ID: 12171015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized trial comparing initial HAART regimens of nelfinavir/nevirapine and ritonavir/saquinavir in combination with two nucleoside reverse transcriptase inhibitors.
    Kirk O; Lundgren JD; Pedersen C; Mathiesen LR; Nielsen H; Katzenstein TL; Obel N; Gerstoft J
    Antivir Ther; 2003 Dec; 8(6):595-602. PubMed ID: 14760893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ritonavir/saquinavir plus one nucleoside reverse transcriptase inhibitor (NRTI) versus indinavir plus two NRTIs in protease inhibitor-naive HIV-1-infected adults (IRIS study).
    Florence E; Dreezen C; Desmet P; Smets E; Fransen K; Vandercam B; Pelgrom J; Clumeck N; Colebunder R
    Antivir Ther; 2001 Dec; 6(4):255-62. PubMed ID: 11878407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delavirdine in rescue regimens.
    TreatmentUpdate; 2002; 14(4):6. PubMed ID: 12064317
    [No Abstract]   [Full Text] [Related]  

  • 40. Rescue regimens: the value of protease-inhibitor boosting.
    Segal-Maurer S; Schütz M
    Body Posit; 2001 Sep; 14(9):11-3. PubMed ID: 11693112
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.